Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents
Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
To determine if ranolazine improves angina symptoms at 4 months compared with placebo among
patients who are deferred for receiving a Percutaneous Coronary Intervention (PCI) based on
the Fractional Flow Reserve (FFR) measurement.
Phase:
Phase 2
Details
Lead Sponsor:
North Florida Foundation for Research and Education